IQVIA Holdings Inc. (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, today announced at NVIDIA GTC the launch of IQVIA.ai, a ...

IQVIA Holdings (NYSE:IQV) has agreed to acquire discovery services assets from Charles River Laboratories. The deal adds in vitro discovery capabilities across five additional sites to IQVIA's ...

Clinical research company IQVIA (NYSE: IQV) reported Q4 CY2025 results exceeding the market’s revenue expectations , with sales up 10.3% year on year to $4.36 billion. The company’s full-year revenue ...

Clinical research company IQVIA (NYSE: IQV) reported Q2 CY2025 results , with sales up 5.3% year on year to $4.02 billion. The company’s full-year revenue guidance of $16.2 billion at the midpoint ...

IQVIA reported strong Q4 2023 earnings, exceeding market expectations, and issued bullish guidance for 2024. The company's R&DS segment saw record net new bookings, indicating high demand for their ...

If you are wondering whether IQVIA Holdings is attractively priced right now, it helps to separate the recent share price ...

IQVIA Holdings Inc. (NYSE:IQV) is one of the 11 Best Affordable Growth Stocks to Buy Now. On March 3, analysts at RBC Capital initiated coverage of IQVIA Holdings Inc. (NYSE:IQV) with an Outperform ...

Iqvia reported fourth-quarter revenue of nearly $4.4 billion, up 10% year over year, with adjusted earnings per share of $3.42, a 9.6% increase. Management guided to 2026 revenue of $17.25 billion at ...

Sylvia Durgerian started working at IQVIA Canada as a business analyst not long after graduating from university three decades ago. She was intrigued by IQVIA’s impact on the life sciences industry ...

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, ...